Suchergebnisse - "145155-23-3"

PubPharm (1.030)

1

Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis : A Case Report and Review of Literature

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Akita, S. | Fujibayashi, K. | Ueno, E. | +3

2

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis : a network meta-analysis

enthalten in: The Cochrane database of systematic reviews | 2024

von Gonzalez-Lorenzo, M. | Ridley, B. | Minozzi, S. | +8

UpdateOf: Cochrane Database Syst Rev. 2015 Sep 18;(9):CD011381. - PMID 26384035

3

Adverse effects of immunotherapies for multiple sclerosis : a network meta-analysis

enthalten in: The Cochrane database of systematic reviews | 2023

von Tramacere, I. | Virgili, G. | Perduca, V. | +8

4

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

5

SATB2, coordinated with CUX1, regulates IL-1β-induced senescence-like phenotype in endothelial cells by fine-tuning the atherosclerosis-associated p16INK4a expression

enthalten in: Aging cell | 2023

von Wu, T. | Wu, Y. | Jiang, D. | +7

6

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir : A Phase 2 Open-label Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Tam, A. | Zhang, R. | Lung, K. | +23

7

Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients : An updated network meta-analysis of 48 randomized controlled trials

enthalten in: Medicine | 2022

von Cheng, Q. | Zhao, G. | Chen, J. | +2

8

Comparative Efficacy of Relapsing Multiple Sclerosis Therapies : Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate

enthalten in: Multiple sclerosis and related disorders | 2022

von Hennessy, B. | Zierhut, M. | Kracker, H. | +2

9

Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis

enthalten in: Molecules (Basel, Switzerland) | 2022

von Ortíz, G. | Briones-Torres, A. | Benitez-King, G. | +3

10

Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS : Results from an Italian Real-World Study

enthalten in: International journal of environmental research and public health | 2022

von Zanghì, A. | D'Amico, E. | Patti, F. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[103]